ACQUITY PREMIER Solution Improves the UPLC-MS Analysis of Deferoxamine – an Iron Chelating Drug

Applications | 2021 | WatersInstrumentation
LC/MS, LC/SQ
Industries
Clinical Research
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

MaxPeak Premier Columns - Small Molecule Application Notebook
USING HYBRID ORGANIC/INORGANIC SURFACE TECHNOLOGY TO  MITIGATE ANALYTE INTERACTIONS WITH METAL SURFACES IN UPLC  SEPARATIONS OF SMALL MOLECULE PHARMACEUTICALS
THE IMPORANCE OF MITIGATING ANALYTE INTERACTIONS WITH METAL SURFACES IN HPLC SEPARATIONS OF SMALL MOLECULES
Using a Systematic Screening Protocol and MaxPeak™ HPS Technology to Develop a UHPLC Method for the Analysis of Deferoxamine and its Forced Degradation Products